Others have case reports
I couldnt believe it. That was right around the time that demand for these medications were leading to a shortages of the injections, The Food and Drug Administration allowed compounding pharmacies to get in the GLP-1 market to fill in the gap with mass-produced weight loss drugs with the same active ingredients as the brand names
Researchers following the regulatory trajectory should monitor the peptide regulatory landscape for updates as trial results become available
GLP-1/exendin-4 facilitates beta-cell neogenesis in rat and human pancreatic ducts
GLP-1 medications have become an important tool in addressing the metabolic changes that often accompany menopause, but its important for patients to understand the difference between FDA-approved, branded therapies and compounded versions
Lisa-Marie Hinzmann discussed how weight, insulin resistance, and metabolic health can impact fertility outcomes, while also addressing growing public conversations surrounding Ozempic babies, pregnancy planning, PMOS, and reproductive health
